These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 30267775)

  • 1. Lower risk of stress fractures in young adults with ADHD under chronic treatment with methylphenidate.
    Schermann H; Ankory R; Shlaifer A; Dolkart O; Rotman D; Yoffe V; Karakis I; Chechik O
    Bone; 2019 Mar; 120():20-24. PubMed ID: 30267775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Previous Methylphenidate Use on Incidence of Stress Fractures in Military Recruits: A Retrospective Cohort.
    Ben-Ami IS; Ankory R; Kadar A; Rotman D; Snir N; Schermann H
    J Bone Joint Surg Am; 2018 Jun; 100(11):930-935. PubMed ID: 29870443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower risk of fractures under methylphenidate treatment for ADHD: A dose-response effect.
    Schermann H; Gurel R; Ankory R; Kadar A; Yoffe V; Snir N; Sternheim A; Karakis I
    J Orthop Res; 2018 Dec; 36(12):3328-3333. PubMed ID: 30129682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of methylphenidate on stress fractures in patients' ages 10-29: a national database study.
    DeFroda SF; Quinn M; Yang DS; Daniels AH; Owens BD
    Phys Sportsmed; 2020 Nov; 48(4):412-416. PubMed ID: 32013692
    [No Abstract]   [Full Text] [Related]  

  • 5. Past Methylphenidate Exposure and Stress Fractures in Combat Soldiers: A Case-Control Study.
    Schermann H; Ben-Ami IS; Tudor A; Amar E; Rath E; Yanovich R
    Am J Sports Med; 2018 Mar; 46(3):728-733. PubMed ID: 29236514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in pain response are partially reversed by methylphenidate (Ritalin) in adults with attention deficit hyperactivity disorder (ADHD).
    Treister R; Eisenberg E; Demeter N; Pud D
    Pain Pract; 2015 Jan; 15(1):4-11. PubMed ID: 24134430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic dysfunction in attention deficit hyperactivity disorder (ADHD), differences between pharmacologically treated and never treated young adults: a 3,4-dihdroxy-6-[18F]fluorophenyl-l-alanine PET study.
    Ludolph AG; Kassubek J; Schmeck K; Glaser C; Wunderlich A; Buck AK; Reske SN; Fegert JM; Mottaghy FM
    Neuroimage; 2008 Jul; 41(3):718-27. PubMed ID: 18424180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.
    Adler LA; Zimmerman B; Starr HL; Silber S; Palumbo J; Orman C; Spencer T
    J Clin Psychopharmacol; 2009 Jun; 29(3):239-47. PubMed ID: 19440077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between methylphenidate treatment and the risk for fracture among young ADHD patients: A nationwide population-based study in Taiwan.
    Chen VC; Yang YH; Liao YT; Kuo TY; Liang HY; Huang KY; Huang YC; Lee Y; McIntyre RS; Lin TC
    PLoS One; 2017; 12(3):e0173762. PubMed ID: 28296941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
    Epstein T; Patsopoulos NA; Weiser M
    Cochrane Database Syst Rev; 2014 Sep; (9):CD005041. PubMed ID: 25230710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of methylphenidate on body index and physical fitness in Korean children with attention deficit hyperactivity disorder.
    Kang KD; Yun SW; Chung U; Kim TH; Park JH; Park IH; Han DH
    Hum Psychopharmacol; 2016 Mar; 31(2):76-82. PubMed ID: 26756111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuity in methylphenidate treatment of adults with attention-deficit/hyperactivity disorder.
    Olfson M; Marcus SC; Zhang HF; Wan GJ
    J Manag Care Pharm; 2007 Sep; 13(7):570-7. PubMed ID: 17874863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytogenetic Effects of Chronic Methylphenidate Treatment and Chronic Social Stress in Adults with Attention-Deficit/Hyperactivity Disorder.
    Kittel-Schneider S; Spiegel S; Renner T; Romanos M; Reif A; Reichert S; Heupel J; Schnetzler L; Stopper H; Jacob C
    Pharmacopsychiatry; 2016 Jul; 49(4):146-54. PubMed ID: 26926233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-acting methylphenidate reduces collision rates of young adult drivers with attention-deficit/hyperactivity disorder.
    Cox DJ; Davis M; Mikami AY; Singh H; Merkel RL; Burket R
    J Clin Psychopharmacol; 2012 Apr; 32(2):225-30. PubMed ID: 22367664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of methylphenidate on oppositional defiant disorder comorbid with attention deficit/hyperactivity disorder.
    Serra-Pinheiro MA; Mattos P; Souza I; Pastura G; Gomes F
    Arq Neuropsiquiatr; 2004 Jun; 62(2B):399-402. PubMed ID: 15273834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to growth hormone in attention deficit hyperactivity disorder: effects of methylphenidate and pemoline therapy.
    Rao JK; Julius JR; Breen TJ; Blethen SL
    Pediatrics; 1998 Aug; 102(2 Pt 3):497-500. PubMed ID: 9685452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medication therapy for attention deficit/hyperactivity disorder is associated with lower risk of fracture: a retrospective cohort study.
    Perry BA; Archer KR; Song Y; Ma Y; Green JK; Elefteriou F; Dahir KM
    Osteoporos Int; 2016 Jul; 27(7):2223-2227. PubMed ID: 26928186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of a novel biphasic controlled-release methylphenidate formula in adults with attention-deficit/hyperactivity disorder: results of a double-blind, placebo-controlled crossover study.
    Jain U; Hechtman L; Weiss M; Ahmed TS; Reiz JL; Donnelly GA; Harsanyi Z; Darke AC
    J Clin Psychiatry; 2007 Feb; 68(2):268-77. PubMed ID: 17335326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADHD in childhood epilepsy: Clinical determinants of severity and of the response to methylphenidate.
    Rheims S; Herbillon V; Villeneuve N; Auvin S; Napuri S; Cances C; Berquin P; Castelneau P; Nguyen The Tich S; Villega F; Isnard H; Nabbout R; Gaillard S; Mercier C; Kassai B; Arzimanoglou A;
    Epilepsia; 2016 Jul; 57(7):1069-77. PubMed ID: 27237724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autonomic correlates at rest and during evoked attention in children with attention-deficit/hyperactivity disorder and effects of methylphenidate.
    Negrao BL; Bipath P; van der Westhuizen D; Viljoen M
    Neuropsychobiology; 2011; 63(2):82-91. PubMed ID: 21178382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.